OTCMKTS:THERF Theratechnologies (THERF) Stock Forecast, Price & News $0.86 -0.09 (-9.45%) (As of 06/1/2023 ET) Add Compare Share Share Today's Range$0.86▼$0.9550-Day Range$0.78▼$1.0152-Week Range$3.58▼$7.29Volume133,276 shsAverage Volume45,196 shsMarket Capitalization$66.37 millionP/E RatioN/ADividend YieldN/APrice TargetN/A ProfileProfileChartCompetitorsHeadlinesProfileChartCompetitorsHeadlines About Theratechnologies (OTCMKTS:THERF) StockTheratechnologies Inc., a specialty pharmaceutical company, addresses unmet medical needs to promote healthy living and improve quality of life among HIV patients. It offers EGRIFTA, for the reduction of excess abdominal fat in HIV-infected patients with lipodystrophy in Canada and the United States; and Trogarz, an injection refers to ibalizumab for the treatment of multidrug resistant HIV-1 infected patients in the United States. The company was founded in 1993 and is headquartered in Montreal, Canada.Read More Receive THERF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Theratechnologies and its competitors with MarketBeat's FREE daily newsletter. Email Address THERF Stock News HeadlinesMay 12, 2023 | americanbankingnews.comTheratechnologies (OTCMKTS:THERF) Stock Passes Above Fifty Day Moving Average of $0.88October 13, 2021 | benzinga.comTheratechnologies Q3 Earnings Lags Consensus As Trogarzo Sales DeclineJune 2, 2023 | Edge On The Street (Ad)The Real Problem With "Made in America" LithiumPoliticians love to say they support "Made in America" when it comes to manufacturing. But when it comes to lithium - the metal fueling our transition to electric vehicles - it's not that simple. September 22, 2021 | feeds.benzinga.comTheratechnologies' IV Push Form Of HIV Treatment At Par With IV InfusionMay 18, 2021 | gurufocus.comWorth Venture Partners, LLC Buys Talend SA, Theratechnologies Inc, DZS Inc, Sells Blue Bird ...May 18, 2021 | gurufocus.comSoleus Capital Management, L.P. Buys Theratechnologies Inc, Krystal Biotech Inc, IVERIC bio ...November 23, 2020 | financialpost.comTheratechnologies to Present at the Piper Sandler Virtual Healthcare ConferenceOctober 15, 2020 | fool.comTheratechnologies Inc. (THTX) Q3 2020 Earnings Call TranscriptJune 2, 2023 | Edge On The Street (Ad)The Graphite Shortage Story You're Not Being ToldGraphite demand for EV batteries is expected to increase 10X from 2020 to 2030. And today, with NO graphite-producing mines in N. America, China has a stranglehold on our graphite supply. That's why the U.S. government is spending billions of dollars to ensure an adequate domestic supply of this metal that's vital for energy independence and national security. October 13, 2020 | feeds.benzinga.comTheratechnologies Confirms Issuance of U.S. Patent Covering the Use of Tesamorelin in the Treatment of Individuals Suffering From NAFLD/NASHOctober 8, 2019 | seekingalpha.comTheratechnologies EPS beats by $0.02, misses on revenueJuly 11, 2019 | seekingalpha.comTheratechnologies Inc. (THERF) CEO Luc Tanguay on Q2 2019 Results - Earnings Call TranscriptJuly 11, 2019 | finance.yahoo.comTheratechnologies, Inc. to Host Earnings CallApril 4, 2019 | seekingalpha.comTheratechnologies Inc. (THERF) CEO Luc Tanguay on Q1 2019 Results - Earnings Call TranscriptMarch 21, 2019 | seekingalpha.comTheratechnologies And NASH In HIV Patients, And The Market AssessmentMarch 14, 2019 | seekingalpha.comTheratechnologies And Egrifta In NASH: A Hidden Gem With Broad Therapeutic PotentialFebruary 22, 2019 | seekingalpha.comTheratechnologies Inc. (THERF) CEO Luc Tanguay on Q4 2018 Results - Earnings Call TranscriptSee More Headlines THERF Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart THERF Company Calendar Last Earnings4/04/2019Today6/01/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS Industry Pharmaceutical Preparations Sub-IndustryN/A SectorMedical Current SymbolOTCMKTS:THERF Previous SymbolNASDAQ:THER CUSIPN/A CIKN/A Webwww.theratech.com Phone514-336-7800FaxN/AEmployees32Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($0.10) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-4,660,000.00 Net Margins-11.57% Pretax MarginN/A Return on Equity-14.31% Return on Assets-4.25% Debt Debt-to-Equity Ratio1.70 Current Ratio2.69 Quick Ratio2.19 Sales & Book Value Annual Sales$45.18 million Price / Sales1.47 Cash Flow$0.00 per share Price / Cash Flow177.07 Book Value$0.47 per share Price / Book1.84Miscellaneous Outstanding Shares76,953,000Free FloatN/AMarket Cap$66.37 million OptionableNot Optionable Beta0.58 Key ExecutivesMr. Luc Tanguay (Age 61)Pres, CEO & Non-Independent Director Mr. Philippe Dubuc MBA (Age 52)Sr. VP & CFO Mr. Jocelyn Lafond (Age 51)VP of Legal Affairs & Corp. Sec. Mr. Denis Boucher B.A. (Age 53)L.L.B., VP of Communications & Corp. Affairs Mr. Christian Marsolais (Age 56)Sr. VP & Chief Medical Officer Key CompetitorsFortress BiotechNASDAQ:FBIOClearside BiomedicalNASDAQ:CLSDBellerophon TherapeuticsNASDAQ:BLPHBolt BiotherapeuticsNASDAQ:BOLTSocietal CDMONASDAQ:SCTLView All Competitors THERF Stock - Frequently Asked Questions How have THERF shares performed in 2023? Theratechnologies' stock was trading at $0.8828 at the beginning of the year. Since then, THERF shares have decreased by 2.3% and is now trading at $0.8625. View the best growth stocks for 2023 here. How were Theratechnologies' earnings last quarter? Theratechnologies Inc (OTCMKTS:THERF) announced its quarterly earnings results on Thursday, April, 4th. The company reported $0.01 EPS for the quarter, meeting the consensus estimate of $0.01. The company had revenue of $15.10 million for the quarter. Theratechnologies had a negative trailing twelve-month return on equity of 14.31% and a negative net margin of 11.57%. What is Theratechnologies' stock symbol? Theratechnologies trades on the OTCMKTS under the ticker symbol "THERF." How do I buy shares of Theratechnologies? Shares of THERF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is Theratechnologies' stock price today? One share of THERF stock can currently be purchased for approximately $0.86. How much money does Theratechnologies make? Theratechnologies (OTCMKTS:THERF) has a market capitalization of $66.37 million and generates $45.18 million in revenue each year. The company earns $-4,660,000.00 in net income (profit) each year or ($0.10) on an earnings per share basis. How can I contact Theratechnologies? Theratechnologies' mailing address is 2015 Peel Street 5th Floor, MONTREAL A8, H3A 1T8. The official website for the company is www.theratech.com. The company can be reached via phone at 514-336-7800 or via email at communications@theratech.com. This page (OTCMKTS:THERF) was last updated on 6/2/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Theratechnologies Inc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.